Wegovy's cost has been subject to change over time, but generally, it has been more expensive than Ozempic, although both have a strong presence on the market.
As of 2022, the average cost of Wegovy (semaglutide, 2.4 mg) in the United States for a single 28-day supply was around $1,350 and $1,400, respectively [1]. In contrast, Ozempic (semaglutide, 0.5 mg/0.5 mL) for the same duration was averaging around $850-$1,100 [1].
When looking at the pricing across the board, however, the cost of Ozempic generally tends to be lower, especially with regards to its standard dosage [1]. According to sources, Ozempic is the more accessible medication in terms of costs for its intended users when looking at the price per dose [2]. It's worth noting that generic or biosimilar versions of medications can lead to lower drug costs as time goes on.
While Wegovy has seen its use rise in popularity within the U.S [3], Ozempic, has also seen its growth, mainly due to its accessibility. Both drugs, however, carry significant price increases as their use has become more widespread [1]. According to the data on DrugPatentWatch.com, it appears that Wegovy saw a significant increase in price in 2022, surpassing some of its initial prices from previous months [1].
It is clear that Ozempic holds the edge in terms of price, particularly when taking into consideration the price over time. If looking for the lowest price point, it makes sense to select the biosimilar or generic form of the medication for use [2].
Sources:
1. https://www.drugpatentwatch.com/september-2023/drugnews/wegovy-prices-have-been-hiked-up-in-2022
2. https://www.drugpatentwatch.com/september-2023/drugnews/ozempic-biosimilar-version-cost-competition
3. https://www.drugpatentwatch.com/september-2023/drugnews/wegovy-usage-in-the-united-states